This inventor holds 4 USPTO granted patents. Top assignees: Ludwig Institute for Cancer Research Limited, Oxford University Innovation Ltd, Other. Active years: 1996-2004.
Location History:
- Headington, GB (1996 - 1997)
- Oxford, GB (1998 - 2004)
Company Filing History:
3 out of 530 
2 out of 483 
1 out of 834,411 Years Active: 1996-2004
Title: Innovations and Contributions of Inventor Judy Bastin
Introduction
Judy Bastin is a prominent inventor based in Oxford, GB. She has made significant contributions to the field of cancer research, particularly in the development of tumor rejection antigens. With a total of 4 patents to her name, her work has had a profound impact on immunotherapy and cancer treatment.
Latest Patents
Among her latest patents is the invention of isolated peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules. These complexes can be utilized to generate cytotoxic T lymphocytes (CTLs) and can be supplemented with interleukin-6 (IL-6) and interleukin-12 (IL-12). Another notable patent involves isolated peptides derived from MAGE tumor rejection antigen precursors. These tumor rejection antigens bind to the MHC-class I molecule HLA-A2, stimulating the production of cytolytic T cell clones that can lyse presenting cells. The peptides and complexes developed by Bastin may be used diagnostically, therapeutically, and as immunogens for the production of antibodies or as targets for generating cytolytic T cell clones.
Career Highlights
Judy Bastin has worked with esteemed organizations such as the Ludwig Institute for Cancer Research Limited and Oxford University Innovation Limited. Her career has been marked by a commitment to advancing cancer research and developing innovative therapeutic solutions.
Collaborations
Throughout her career, Bastin has collaborated with notable colleagues, including Alan Townsend and Thierry R Boon-Falleur. These collaborations have further enriched her research and contributed to her success as an inventor.
Conclusion
Judy Bastin's contributions to cancer research through her innovative patents and collaborations highlight her significant role in the field. Her work continues to inspire advancements in immunotherapy and cancer treatment.